Hospital
Prime Healthcare Services-Suburban Hospital LLC
Prime Healthcare Services-Suburban Hospital LLC was paid $4.49M by Medicaid between Oct 2019 and Dec 2024, across 53 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoPRIME HEALTHCARE SERVICES-SUBURBAN HOSPITAL LLC
EAST NORRITON, PA 19401
EAST NORRITON, PA 19401
33aNPI1124495239assigned 08/24/2015
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.49M
24GClaims38,457
24DCodes billed53
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#66 of 154
Median peer was paid$2.82M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 72 | $1K | |
| 2020 | 3,466 | $318K | |
| 2021 | 11,745 | $1.37M | |
| 2022 | 6,610 | $1.16M | |
| 2023 | 9,318 | $1.06M | |
| 2024incomplete | 7,246 | $583K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 6,252 | 5,907 | $1.50M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 4,792 | 4,574 | $1.08M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 4,345 | 4,155 | $872K |
| G0378 | Hospital observation service, per hour | 16% | 511 | 421 | $699K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.0% | 1,467 | 1,366 | $179K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 687 | 629 | $50K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 325 | 296 | $44K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 161 | 154 | $18K |
| 80053 | Comprehensive metabolic panel | <1% | 3,242 | 2,857 | $8K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 48 | 43 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 76 | 76 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,303 | 2,900 | $4K |
41 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 171 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 271 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 296 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 187 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 15 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 739 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 76 | $1K |
| 82550 | <1% | 972 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 647 | $1K |
| 84484 | <1% | 591 | $979.73 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 449 | $805.06 |
| 83690 | <1% | 584 | $525.52 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 54 | $454.22 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 109 | $428.23 |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,553 | $380.57 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 30 | $315.00 |
| 85730 | <1% | 159 | $218.03 | |
| 80320 | <1% | 125 | $211.68 | |
| 85610 | <1% | 184 | $178.19 | |
| 73630 | <1% | 27 | $165.39 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,979 | $160.71 |
| 84702 | <1% | 58 | $150.90 | |
| 81001 | <1% | 250 | $149.71 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 94 | $129.04 |
| 81003 | <1% | 239 | $112.25 | |
| 81025 | <1% | 191 | $100.48 | |
| 85379 | <1% | 52 | $53.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 742 | $47.87 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | $37.44 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 28 | $25.78 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 600 | $17.36 |
| 82962 | <1% | 76 | $12.00 | |
| J3490 | Unclassified drugs | <1% | 505 | $5.97 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 16 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 14 | $0.00 |
| 84100 | 0% | 36 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 15 | $0.00 |
| 83735 | 0% | 36 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 33 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 17 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.